Today’s AI Top Pick: ACI

8/3/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · ContrarianACIBUY NOW8.2 / 108/3/2026

Albertsons (ACI) is the cleanest contrarian bounce setup in this pool: multi-timeframe alignment is unanimous with 1h/4h/1d/1wk all forecasting up (short-term 38.45–50.57%, mid 40.63–61.75%, long 41.00–71.34%), bullish_prob=1.0 and near_term_bullish=1.0. Crucially, price sits at 0–15.56% of its 21-bar range across all timeframes with drawdowns of −18.47% to −31.66% — deeply oversold (RSI 31.84), not at fresh lows on the shortest timeframes (dd from 21-bar high only −21.45% on 1h), which is exactly the 'exhausted selling, not broken trend' profile the lens is looking for. What separates ACI from the rest of the field is that the news flow is actually a POSITIVE catalyst rather than a landmine. On 2026-07-29 an EVP made a $1.96M open-market buy — insider capitulation-buying at the bottom is one of the most reliable contrarian tells. Compare that to the wreckage elsewhere: ALNY (earnings miss + guide cut, −28% drop), MYGN (guidance cut), PSN (shareholder investigations + guide cut), LII (2026 EPS cut), MNRO (PT cuts), EVH (Citi downgrade + PT to $5), CDXS (16.7M share dilution), CANG (1-for-10 reverse split). Most 'strong forecast' names here have their thesis actively undercut by a recent headline. ACI does not. Fundamentals are defensible for a defensive-consumer name: PS 0.07 (extremely cheap on sales), ROE 2.72%, positive profitMargin (0.08%) and operMargin (1.96%), salesYoY +2.75%, market cap $5.62B — this is not a speculative micro-cap where a squeeze can vaporize you. Yes, fwdPe is unhelpful (null), PE 154 is optically stretched, debtEq 9.74 is high, and shortFloat 15.52% is elevated — but for a grocery chain trading down −39.75% YoY with an insider stepping in with real money, the risk/reward at $11.63 is favorable. The forecast asymmetry (short ~+40%, long ~+50–70%) combined with a real catalyst and no fresh negative headline is why TODAY beats waiting: pullback-buyers waiting for a re-test may miss the reversion move that the insider is signaling. Runners-up like CMTG and LODE have similar TF alignment but weaker catalysts and worse fundamentals (CMTG profitMargin −302%, LODE PS 206); MNRO has clean TF alignment but PT cuts and a strategic review overhang; NAUT is intriguing but PS 654 and profitMargin −29,748% make it a lottery ticket.

Entry zone

$11.50–$11.75 (buy at/near current $11.63; add on any dip to $11.30)

Stop loss

$10.60 (below 21-bar low; ~8.9% risk)

First target

$13.80 (≈+18.7%, aligns with 1h/4h short-horizon forecast of +41–50% but conservative for first take)

Longer target

$16.50–$17.00 (≈+42–46%, aligns with 1wk long-horizon +71% and mid-horizon 4h/1d +45–48%)

Risks

Debt/Equity of 9.74 is extreme — any credit market stress hits ACI disproportionately
TTM PE 154.81 with razor-thin profitMargin 0.08% means small earnings misses translate to large percentage moves
Short float 15.52% can accelerate the bounce but also indicates real bearish conviction
Recommendation is only 2.6 (Hold-leaning) with modest targetUpsidePct of 22.5%, so analyst community is not enthusiastic
Perf YTD −32.56% and perfYear −39.75% shows persistent downtrend — a lower-high failure would confirm broken trend not bounce

Honorable mentions

CMTGClean multi-TF bullish forecasts (1h/4h/1d/1wk all up, mid-horizon +57–66%), position 0% of range across every TF, no landmine headlines just a routine Q2 earnings call. Held back by −302% profit margin and mortgage-REIT credit exposure.

LODEAll TFs align bullish with moderate but consistent forecasts (short +18–35%, mid +17–38%), position 0–1.89% of range, no adverse news post-Q2. Weaker forecast magnitude and PS 206 keep it behind ACI/CMTG.

Full ranking (29)

#	Symbol	Verdict	Score	Read
1	ACI	BUY NOW	8.2	All-TF bullish, near lows of 21-bar range, $1.96M EVP insider buy is the positive catalyst absent everywhere else.
2	CMTG	BUY NOW	7.4	Every timeframe forecasts up 26–74%, sits at 0% of range on all TFs, no negative headline.
3	LODE	BUY NOW	6.8	Consistent all-TF bullish forecasts with position 0–1.9% of range and no adverse news post-Q2.
4	MNRO	BUY PULLBACK	6.6	All-TF bullish (+24–71%) at 0% of range, but Stephens PT cut to $17 and strategic review add overhang.
5	NAUT	BUY PULLBACK	6.3	Massive forecasts (+79–186%), contrarian SA article, all TFs bullish — but PS 654 and profit margin −29,748% are extreme.
6	LEGN	BUY PULLBACK	6.1	$3.45B biotech with all-TF bullish forecasts, but CEO resignation this week creates management-transition risk.
7	ADTN	BUY PULLBACK	5.9	Strong 1h/4h forecasts (+56–88%) and low position in range, but 1wk forecast is slightly negative (−7.6% mid) and multiple PT cuts.
8	GXAI	BUY PULLBACK	5.6	Strong forecasts +60–91% across 1h/4h/1d and RSI 17, but micro-cap $8M and post-divestiture noise.
9	NXL	WAIT	5.4	Mid/long forecasts positive but weekly is only +22–35% and recent bar action already showing bounce (1h +1.53% on 4h).
10	CDXS	WAIT	5.2	Multi-TF forecasts positive but 16.7M-share prospectus filed July 24 is fresh dilution overhang.
11	INDP	WAIT	5.1	Enormous 1d/1wk forecasts (+226/+969%) but tiny biotech with no financials and 4h at −64.5% dd — knife-catch.
12	CNCK	WAIT	5.0	Big weekly forecast (+470%) but 56M-share resale prospectus creates supply overhang; 1h forecast basically flat.
13	ALNY	BUY PULLBACK	4.8	Best fundamentals in pool (fund score 8) with massive forecasts, but Q2 miss + 2026 guide cut just hit — needs stability first.
14	AIFA	WAIT	4.5	Only 2 TFs, weekly forecast +330% is extreme; micro-cap with no clear catalyst.
15	NXTC	WAIT	4.3	Reverse-merger/CVR structure post-Avere deal — 1d already up 104%, sits at 50% of range, entry is chasing.
16	FIDA-USD	WAIT	4.1	Only 1h/4h data available, modest forecasts +24–30% mid — thin signal set.
17	LII	WAIT	4.0	Quality name and forecasts positive but 2026 EPS guide just cut, GS trimmed PT — needs digestion time.
18	EIGEN-USD	WAIT	3.8	Near_term_bullish only 0.2, 1h/4h forecasts near flat, price flat despite whale activity.
19	NIXX	WAIT	3.5	1h forecast negative (−3.6 to −7.7%) undercuts the daily bullish read; micro-cap $15M.
20	MYGN	AVOID	3.2	2026 revenue outlook cut, prenatal test weakness — fresh guide-cut landmine dominates the bounce signal.
21	PSN	AVOID	3.0	Shareholder investigations post 2026 guidance cut and net loss — thesis actively broken.
22	EVH	AVOID	2.9	Citi downgrade + TD Cowen PT slashed to $5 — analysts cutting into the drop.
23	TVRD	AVOID	2.8	Near_term_bullish 0, 1d short-horizon forecast negative, ATM offering expanded to $9.69M = dilution.
24	LNAI	AVOID	2.6	Weekly forecast −5.75% across all horizons; profit margin −612,568% — capital-destruction machine.
25	SDOT	AVOID	2.4	1h forecast −31.58% directly contradicts the daily bullish read; resale prospectus adds supply.
26	AKTX	AVOID	2.2	1h forecast −43 to −50% across all horizons; 1wk forecast −100% flags likely delisting/reverse-split risk.
27	CANG	AVOID	2.0	1h/4h forecasts −24 to −64% after post-reverse-split spike; sits at 100% of range = chasing the top.
28	AIIO	AVOID	1.8	1h forecast −93%, fresh 36.4M-share resale prospectus; profit margin −17,614%.
29	CLRO	AVOID	1.6	4h up 48.9% already (not oversold), targetUpsidePct −2%, salesYoY −81%, fund score −3.25.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord